Abbott Laboratories (ABT)
110.36
-2.11
(-1.88%)
USD |
NYSE |
Aug 31, 16:00
110.37
+0.01
(+0.01%)
After-Hours: 20:00
Abbott Laboratories Cash from Operations (TTM) : 9.905B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.905B |
| March 31, 2026 | 9.464B |
| December 31, 2025 | 9.566B |
| September 30, 2025 | 9.119B |
| June 30, 2025 | 9.037B |
| March 31, 2025 | 8.95B |
| December 31, 2024 | 8.558B |
| September 30, 2024 | 8.728B |
| June 30, 2024 | 7.90B |
| March 31, 2024 | 7.143B |
| December 31, 2023 | 7.261B |
| September 30, 2023 | 6.549B |
| June 30, 2023 | 7.452B |
| March 31, 2023 | 8.659B |
| December 31, 2022 | 9.581B |
| September 30, 2022 | 10.32B |
| June 30, 2022 | 10.24B |
| March 31, 2022 | 9.961B |
| December 31, 2021 | 10.53B |
| September 30, 2021 | 11.26B |
| June 30, 2021 | 10.63B |
| March 31, 2021 | 9.823B |
| December 31, 2020 | 7.901B |
| September 30, 2020 | 6.519B |
| June 30, 2020 | 6.401B |
| Date | Value |
|---|---|
| March 31, 2020 | 6.139B |
| December 31, 2019 | 6.136B |
| September 30, 2019 | 5.485B |
| June 30, 2019 | 5.72B |
| March 31, 2019 | 5.904B |
| December 31, 2018 | 6.30B |
| September 30, 2018 | 6.175B |
| June 30, 2018 | 5.997B |
| March 31, 2018 | 6.104B |
| December 31, 2017 | 5.57B |
| September 30, 2017 | 5.10B |
| June 30, 2017 | 4.312B |
| March 31, 2017 | 3.87B |
| December 31, 2016 | 3.203B |
| September 30, 2016 | 2.861B |
| June 30, 2016 | 2.839B |
| March 31, 2016 | 2.871B |
| December 31, 2015 | 2.966B |
| September 30, 2015 | 3.376B |
| June 30, 2015 | 3.382B |
| March 31, 2015 | 3.341B |
| December 31, 2014 | 3.675B |
| September 30, 2014 | 4.062B |
| June 30, 2014 | 3.383B |
| March 31, 2014 | 3.200B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Becton, Dickinson & Co. | 3.261B |
| Boston Scientific Corp. | 4.529B |
| DexCom, Inc. | 1.749B |
| Insulet Corp. | 511.30M |
| Intuitive Surgical, Inc. | 3.706B |